TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search
PRESS RELEASES

Kodiak Sciences Announces Upcoming Presentation Of KSI-301 Phase 1b Clinical Study Data At Angiogenesis, Exudation, And Degeneration 2021 - Virtual Edition

PRESS RELEASES

Kodiak Sciences To Present At The J.P. Morgan Healthcare Conference

PRESS RELEASES

Kodiak Sciences Announces Closing Of $645.0 Million Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares

PRESS RELEASES

Kodiak Sciences Announces Pricing Of $560.9 Million Public Offering Of Common Stock

PRESS RELEASES

Kodiak Sciences Announces Proposed Offering Of Common Stock

PRESS RELEASES

Kodiak Sciences Completes Enrollment Of DAZZLE Phase 2b/3 Pivotal Study Of KSI-301 In Patients With Wet Age-Related Macular Degeneration

PRESS RELEASES

Kodiak Sciences To Present At Upcoming Conferences

PRESS RELEASES

Kodiak Sciences Announces Presentation Of KSI-301 Phase 1b Clinical Study Data Focused On Diabetic Macular Edema At American Academy Of Ophthalmology (AAO) 2020 Virtual Meeting

PRESS RELEASES

Kodiak Sciences Treats First Patients In Three Phase 3 Studies Of KSI-301 - Two Studies In Diabetic Macular Edema And One Study In Macular Edema Due To Retinal Vein Occlusion

PRESS RELEASES

Kodiak Sciences To Present At Upcoming Conferences

PRESS RELEASES

Kodiak Sciences To Host R&D Webcast To Review Recent Data From The Ongoing Phase 1b Study Of KSI-301 And Highlight KSI-301 Clinical Development Progress

PRESS RELEASES

Kodiak Sciences Announces Upcoming Presentation Of KSI-301 Clinical Study Data At American Society Of Retina Specialists (ASRS) 2020 Virtual Annual Meeting And R&D Webinar

PRESS RELEASES

Kodiak Sciences To Present At Upcoming Conferences

PRESS RELEASES

Kodiak Sciences To Present At The Bank Of America Merrill Lynch Health Care Conference

PRESS RELEASES

Kodiak Sciences To Host First Quarter 2020 Business Highlights Webcast On May 12, 2020

PRESS RELEASES

Kodiak Sciences Appoints Charles Bancroft To Board Of Directors

PRESS RELEASES

"Kodiak" And "Kodiak Sciences" Trademarks Registered To Kodiak Sciences Inc. For Its Exclusive Use

PRESS RELEASES

Kodiak Sciences To Present At Upcoming Conferences

PRESS RELEASES

Kodiak Sciences Announces Upcoming Presentation Of Additional KSI-301 Phase 1b Clinical Study Data At Angiogenesis, Exudation, And Degeneration 2020 Meeting

PRESS RELEASES

Kodiak Sciences To Present At 38th Annual J.P. Morgan Healthcare Conference

PRESS RELEASES

Kodiak Sciences Announces Pricing Of $276.0 Million Public Offering Of Common Stock